MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies

NCT00129155 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Hematological Malignancies
Allogeneic Transplantation

Interventions

DRUG: treosulfan

Sponsor

Hospices Civils de Lyon